Therefore, fenofibrate might be available to prevent the development of prediabetes and type 2 diabetes by improving insulin sensitivity and decreasing the secreting load of β-cells in hypertriglyceridemia patients with normal glucose tolerance. This evidence concerns the gene INS and type 2 diabetes mellitus.